Advertisement
Screener

Femasys Inc. (FEMY) Deferred Offering Costs

2.8 / 5 stars · 68/120 Roast Me

Femasys Inc. Deferred Offering Costs

Femasys Inc. (FEMY) had Deferred Offering Costs of $15.64 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:DeferredOfferingCosts · last filed 2026-03-31

  • 2025-12-31: Deferred Offering Costs $15.64K.
  • 2024-12-31: Deferred Offering Costs $3.14K.
  • 2023-12-31: Deferred Offering Costs $17.95K.
  • 2022-12-31: Deferred Offering Costs $95.00.
Period endDeferred Offering CostsDeferred Offering Costs as first filed
2025-12-31$15.64K
10-K · filed 2026-03-31
2024-12-31$3.14K
10-K · filed 2026-03-31
2023-12-31$17.95K
10-K · filed 2025-03-27
2022-12-31$95.00
10-K · filed 2024-03-28
2022-07-01$150.00M
10-K · filed 2025-03-27
2021-06-30$1.59M
10-K/A · filed 2023-07-24
$1.59M
10-Q · filed 2021-08-11
2021-06-22$1.59M
10-Q · filed 2021-11-12
2021-05-31$188.54K
10-K/A · filed 2023-07-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
ACCURAY INC (ARAY)United States$0.027B-0.63
Glucotrack, Inc. (GCTK)United States$0.027B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Picard Medical, Inc. (PMI)United States$0.011B-0.01